TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
98 hedge funds and large institutions have $900M invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 35 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
21% more capital invested
Capital invested by funds: $742M → $900M (+$158M)
Holders
98
Holding in Top 10
5
Calls
$425K
Puts
–
Top Buyers
| 1 | +$23.4M | |
| 2 | +$20M | |
| 3 | +$15.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$11.8M |
Top Sellers
| 1 | -$9.14M | |
| 2 | -$3.05M | |
| 3 | -$1.91M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.85M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.26M |